These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The role of photodynamic therapy in ophthalmology. Sivaprasad S; Hykin P Br J Hosp Med (Lond); 2006 Dec; 67(12):647-50. PubMed ID: 17328448 [No Abstract] [Full Text] [Related]
6. Photodynamic therapy for age-related macular degeneration: a candid appraisal. Sternberg P; Lewis H Am J Ophthalmol; 2004 Mar; 137(3):483-5. PubMed ID: 15013872 [No Abstract] [Full Text] [Related]
10. Photodynamic therapy with verteporfin: observations on the introduction of a new treatment into clinical practice. Schein OD; Bressler NM; Price P Arch Ophthalmol; 2005 Jan; 123(1):58-63. PubMed ID: 15642813 [TBL] [Abstract][Full Text] [Related]
13. PET myocardial perfusion imaging for the detection of coronary artery disease--clinical assessment, vol. 10, no. 21, 1995. Tecnologica; 1996 Jan; ():7-8. PubMed ID: 10170484 [No Abstract] [Full Text] [Related]
14. High dose lymphoablative therapy (HDLT) with or without stem cell rescue for treatment of severe autoimmune diseases. Tecnologica MAP Suppl; 2000 Apr; ():10-2. PubMed ID: 11010674 [No Abstract] [Full Text] [Related]
15. Update on photodynamic therapy. Regillo CD Curr Opin Ophthalmol; 2000 Jun; 11(3):166-70. PubMed ID: 10977221 [TBL] [Abstract][Full Text] [Related]
16. Sacral nerve stimulation for the treatment of urge incontinence. Tecnologica MAP Suppl; 1998 Aug; ():10-3. PubMed ID: 10342977 [No Abstract] [Full Text] [Related]
17. Verteporfin photodynamic therapy in the UK: implications of the NICE appraisal. Harding S Eye (Lond); 2003 Mar; 17(2):119-22. PubMed ID: 12640394 [No Abstract] [Full Text] [Related]